Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023 Both Eli Lilly and Novo Nordisk scramble to rectify supply shortages Dec 28, 2022
New Hypercalcemia Guideline; Untreated Hyperparathyroidism Risky; PFAS Phase-Out News and commentary from the endocrinology world Dec 27, 2022
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
Glycemic Control With Insulin Barely Budged Over the Past 30 Years Rates of hyperglycemia also remained elevated for racial and ethnic minorities Dec 20, 2022
Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
Fecal Transplant Failed to Boost Effects of Bariatric Surgery No impact on weight loss or metabolism compared with placebo, small study found Dec 16, 2022
Innovation Is Critical to Stop Disparities in Diabetes Care We must explore how new technologies can help Dec 10, 2022
Fewer Hospitalizations With Farxiga; New Obesity Drug; Sotagliflozin Still in Limbo News and commentary from the endocrinology world Dec 06, 2022
Treating Obesity Should Be Our Healthcare Moonshot Behavioral health changes alone will only do so much Nov 21, 2022
FDA Approves First Drug to Delay Onset of Type 1 Diabetes Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
Mixed Results With Pemafibrate in Patients With Type 2 Diabetes No impact on CV events in PROMINENT; developer brings trial to an end Nov 06, 2022
Psilocybin for Depression; What's the Best Direct Oral Anticoagulant? Also in TTHealthWatch: hormone therapy to prevent chronic disease Nov 05, 2022 podcast
Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
Low-Carb Diet Helps Cut HbA1c in Prediabetes Could be a useful approach for preventing, treating type 2 diabetes, says researcher Oct 26, 2022
Lyumjev OK'd for Kids; Sand for Weight Loss? AGA's New Obesity Guidelines News and commentary from the endocrinology world Oct 25, 2022
Adding Electric Stimulation Bests Pyloroplasty Alone for Gastroparesis Randomized trial showed improved symptoms at 3 months with gastric electrical stimulation Oct 25, 2022
It's Time to Retire BMI as a Clinical Metric An undue focus on weight can lead to patient distrust and delayed care Oct 19, 2022
Insulin Rationing Common Among Patients With Diabetes More than a million Americans may be engaging in the risky practice, researchers said Oct 17, 2022
Tirzepatide Fast-Tracked for Weight Loss; Geographical PCOS; New AID Guidelines News and commentary from the endocrinology world Oct 11, 2022
SGLT2 Inhibitors, GLP-1 RAs Not Cost-Effective as First-Line T2D Agents Cost-effectiveness study compared lifetime costs with first-line metformin Oct 03, 2022
Incidence of Dry Eye Disease Lower With SGLT2 Inhibitors Retrospective study in Taiwan reported 22% risk reduction compared with GLP-1 receptor agonists Sep 24, 2022
Women With Type 2 Diabetes Die Sooner Than Men, Study Suggests Other groups at risk for early mortality include smokers, those diagnosed at younger ages Sep 23, 2022
Hysterectomy: Another Diabetes Risk Factor? Preservation of ovaries played into this association Sep 22, 2022
Eye Damage Can Start in Prediabetes Study found significant corneal nerve damage even before full-blown type 2 diabetes Sep 22, 2022
Our Hands Are Tied: Treating Prediabetes in Kids We urgently need more research on pharmacological interventions for this growing epidemic Sep 14, 2022
Do Some ·¬ΗΡΙηΗψ Need to Get Better at Documenting Hypertension in Patient Notes? Study finds settings where BP documentation is especially lax Sep 11, 2022
ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos? News and commentary from the endocrinology world Sep 07, 2022
Prescribing of Newer Diabetes Drugs Not Up to Snuff in Black Patients? Study among veterans suggests disparities in prescription rates for these type 2 diabetes drugs Sep 06, 2022
Racial Differences in Bariatric Surgery Safety Persist Minority groups saw more weight loss with one procedure, but also more complications Aug 31, 2022
FDA Data Link Diabetes Drug Class to Gallbladder Disease FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists Aug 30, 2022
How Have Glucagon Costs Changed in Recent Years? Wholesale costs spiked from 2010 to 2020, but out-of-pocket prices remained mostly stable Aug 30, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
Combining Common Diabetic Nerve Pain Drugs Helped Provide More Relief No specific combination stood out among the crowd Aug 24, 2022
Can Lower Gestational Diabetes Cutoff Improve Outcomes in Kids? About 9% of babies born large for gestational age regardless of the approach to diagnosis Aug 17, 2022
Minimally Invasive Bariatric Procedure Effective for Milder Obesity Big weight loss seen in patients with mild and moderate levels of obesity Aug 02, 2022
Dear Insurers: It's Time to Cover Weight Loss Drugs Universal coverage can increase medication access and improve population health Jul 27, 2022
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
Keto Versus Mediterranean Diet: Which Is Better for Diabetes? Crossover study looked at cardiometabolic outcomes for each popular diet Jul 08, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
